Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,122 | 143 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $232.64 | 18 | $0 (2021) |
| Gilead Sciences, Inc. | $232.63 | 16 | $0 (2021) |
| GlaxoSmithKline, LLC. | $171.95 | 13 | $0 (2020) |
| Lilly USA, LLC | $155.37 | 12 | $0 (2021) |
| Amarin Pharma Inc. | $143.55 | 10 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $138.22 | 10 | $0 (2017) |
| Indivior Inc. | $136.57 | 9 | $0 (2020) |
| Daiichi Sankyo Inc. | $117.18 | 8 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $112.95 | 6 | $0 (2017) |
| Insulet Corporation | $84.53 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $195.34 | 14 | ViiV Healthcare Company ($89.44) |
| 2020 | $188.62 | 14 | ViiV Healthcare Company ($91.34) |
| 2019 | $563.34 | 42 | Lilly USA, LLC ($115.19) |
| 2018 | $188.89 | 13 | GlaxoSmithKline, LLC. ($67.33) |
| 2017 | $985.60 | 60 | Merck Sharp & Dohme Corporation ($138.22) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 6 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/11/2017 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Endocrinology | ||||||
| 05/08/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Hypertriglyceridemia | ||||||
| 05/02/2017 | Janssen Pharmaceuticals, Inc | INVOKAMET (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/19/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: RESPIRATORY | ||||||
| 04/04/2017 | Janssen Pharmaceuticals, Inc | INVOKAMET (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/27/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/13/2017 | Merck Sharp & Dohme Corporation | CUBICIN RF (Drug), ZERBAXA, SIVEXTRO | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/28/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Urology | ||||||
| 02/27/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $12.42 | General |
| 02/27/2017 | ViiV Healthcare Company | TIVICAY (Drug), TRIUMEQ | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: HIV | ||||||
| 02/23/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/15/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $15.44 | General |
| 02/07/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Opioid Induced Constipation | ||||||
| 02/04/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: OUD | ||||||
| 01/31/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Urology | ||||||
| 01/17/2017 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/09/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 65 | 101 | $17,083 | $9,422 |
| 2020 | 2 | 44 | 63 | $8,125 | $4,040 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 26 | $6,341 | $4,227 | 66.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 41 | $7,437 | $4,158 | 55.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 22 | $3,305 | $1,037 | 31.4% |
| 91300 | Sarscov2 vac 30mcg/0.3ml im | Office | 2021 | 11 | 12 | $0.12 | $0.12 | 100.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 26 | $3,771 | $2,246 | 59.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 37 | $4,354 | $1,793 | 41.2% |
About Dr. Randa Hamadeh, M.D
Dr. Randa Hamadeh, M.D is a Infectious Disease healthcare provider based in Bayonne, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184698151.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randa Hamadeh, M.D has received a total of $2,122 in payments from pharmaceutical and medical device companies, with $195.34 received in 2021. These payments were reported across 143 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,122).
As a Medicare-enrolled provider, Hamadeh has provided services to 109 Medicare beneficiaries, totaling 164 services with total Medicare billing of $13,462. Data is available for 2 years (2020–2021), covering 6 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Other Specialties Internal Medicine, Infectious Disease
- Location Bayonne, NJ
- Active Since 02/15/2006
- Last Updated 06/24/2016
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184698151
Products in Payments
- DOVATO (Drug) $220.24
- Vascepa (Drug) $143.55
- ANORO (Drug) $119.38
- Omnipod (Device) $84.53
- Movantik (Drug) $81.16
- SUBLOCADE (Drug) $72.19
- HUMULIN (Drug) $65.64
- SUBOXONE SUBLINGUAL FILM (Drug) $64.38
- Myrbetriq (Drug) $58.01
- INVOKANA (Drug) $55.36
- FARXIGA (Drug) $50.34
- AFREZZA (Drug) $45.88
- JANUVIA (Drug) $45.01
- BAQSIMI (Drug) $44.36
- EVENITY (Biological) $41.52
- INVOKAMET (Drug) $37.14
- PREVNAR - 13 (Biological) $35.68
- TRULICITY (Drug) $33.43
- XIFAXAN (Drug) $32.80
- PREZCOBIX (Drug) $29.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.